Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Gilead Sciences (GILD) Tops Q4 EPS by 4c, Offers FY Guidance
February 4, 2021 4:03 PM ESTGilead Sciences (NASDAQ: GILD) reported Q4 EPS of $2.19, $0.04 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.42 billion versus the consensus estimate of $7.33 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $6.75-$7.45, versus the consensus of... More
